McKesson vs Moderna

McKesson (MCK), health care, and Moderna (MRNA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

McKesson is worth $127B on the stock market and Moderna $83.9B: McKesson is valued at 51% more. McKesson's operating margin in its latest fiscal year was 1.54% and Moderna's -158%. Over the past year McKesson's share price has moved +28.4% and Moderna's +764%.

Key facts

McKesson market value
$127B
Moderna market value
$83.9B
McKesson P/E
28.4
McKesson revenue
$403.4BFY to 2026-03-31
Moderna revenue
$1.9BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

McKesson vs Moderna: every measure side by side
Measure McKesson Moderna
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2026-03-312025-12-31
Size
Market cap$127Bhigher$83.9Blower
Revenue$403.4Bhigher$1.9Blower
Earnings$4.8Bhigher-$2.8Blower
Employees41,600higher4,700lower
Total assets$82.3Bhigher$12.3Blower
Valuation
P/E28.4—
P/S0.3lower43.2higher
P/B—12.3
Dividend yield0.31%higher0.00%lower
Profitability
Operating margin1.54%higher-158%lower
Balance sheet
Net assets-$2.2Blower$8.7Bhigher
Total liabilities$83.2Bhigher$3.7Blower
Total debt$6.5Bhigher$590Mlower
Cash on hand$4Bhigher$2.6Blower
Price change
Today-0.48%higher-3.65%lower
1 year+28.4%lower+764%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns MCK · Who owns MRNA

Further comparisons

Learn

Questions and answers

Which is bigger, McKesson or Moderna?

By market value, McKesson is the larger: $127B against $83.9B for Moderna. By revenue in its latest fiscal year, McKesson is the larger: $403.4B against $1.9B for Moderna.

Which has the higher operating margin?

McKesson: 1.54%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

McKesson: 0.31%, against 0.00% for Moderna. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

McKesson: $6.5B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both McKesson and Moderna?

None of the tracked superinvestors holds both in their latest 13F filing. 13 hold McKesson and 2 hold Moderna.

Cite this page

Funkfolio, “McKesson vs Moderna”, data as of 17 November 2026. https://funkfolio.com/compare/mck-vs-mrna

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.